Vimab Group AB (FRA:NM4) ROCE % : 23.65% (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vimab Group AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vimab Group AB's annualized ROCE % for the quarter that ended in Sep. 2023 was 23.65%.

Vimab Group AB ROCE % Historical Data

The historical data trend for Vimab Group AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimab Group AB ROCE % Chart

Vimab Group AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

14.80

4.53

-14.06

-22.41

-28.72

Vimab Group AB Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															59.05	-103.20	-1.65	21.15	23.65

Vimab Group AB ROCE % Calculation

Vimab Group AB's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-2.618	/	( ( (16.383 - 6.946)	+	(17.851 - 9.057) )	/ 2 )
	=	-2.618	/	( (9.437	+	8.794)	/ 2 )
	=	-2.618	/	9.1155
	=	-28.72 %

Vimab Group AB's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	3.136	/	( ( (23.164 - 12.572)	+	(25.583 - 9.659) )	/ 2 )
	=	3.136	/	( ( 10.592	+	15.924 )	/ 2 )
	=	3.136	/	13.258
	=	23.65 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Vimab Group AB (FRA:NM4) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vimab Group AB ROCE % Related Terms

Thank you for viewing the detailed overview of Vimab Group AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vimab Group AB (FRA:NM4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Vimab Group AB (FRA:NM4) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

VIMAB:Sweden

Address

Malmskillnadsgatan 40A, Stockholm, SWE, 111 57

Website

https://www.vimabgroup.com

Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.

Vimab Group AB (FRA:NM4) Headlines

No Headlines